Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenoten for children in pediatric anxiety disorders
NCT05605938Phase 4Completed
- Sponsor
- Materia Medica Holding
- Start
- Jul 2010
- Primary completion
- Oct 2011
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anxiety disorder comparing Tenoten for children with Placebo (2 arms). Primary endpoints: Changes in Spence Children's Anxiety Scale scores at 12 weeks, Changes in severity of anxiety according to test of R.Temple, V.Amen, M.Dorky at 12 weeks and 1 more. Started Jul 2010; status: completed.
02
Drugs
Tenoten
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT05605938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05605938.